Cladribine regimen for treating multiple sclerosis

Details for Australian Patent Application No. 2007253254 (hide)

Owner Laboratoires Serono S.A.

Inventors Ammoury, Nazih; Brentzel Jr., H. James; Lopez-Bresnahan, Maria

Agent Griffith Hack

Pub. Number AU-A-2007253254

PCT Pub. Number WO2007/135172

Priority 60/845,470 18.09.06 US; 06114537.1 24.05.06 EP

Filing date 23 May 2007

Wipo publication date 29 November 2007

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/7056 (2006.01)

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/135172 Priority application(s): WO2007/135172

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007253255-Corneal implant and method for correction of impaired vision in the human eye

2007253249-A rotary displacement pump with space-saver radial